The Fanconi anemia pathway is required for efficient repair of stress-induced DNA damage in haematopoietic stem cells

Within regenerating tissues, aging is characterized by a progressive general deterioration of organ function, thought to be driven by the gradual depletion of functional adult stem cells. Although there are probably multifactorial mechanisms that result in compromized stem cell functionality with advancing age, the accumulation of DNA damage within the stem cell compartment is likely to make a major contribution to this process. However, the physiologic source of DNA damage within the different tissue specific stem cell compartments remains to be determined, as does the fate of stem cells exposed to such damage. Using the haematopoietic system as a model organ, we have recently shown that certain forms of physiologic stress, such as infection-associated inflammation and extensive blood loss, leads to the induction of biologically relevant levels of DNA damage in haematopoietic stem cells (HSCs) by dramatically increasing the proliferative index of this normally quiescent cell population.1 We were also able to demonstrate that such stress-associated DNA damage was sufficient to completely deplete HSCs and promote severe aplastic anemia (SAA) in the Fanconi anemia (FA) knockout mouse model, which has compromized replication-associated DNA repair. In this “Extra Views” article, we extend this previous work to show that FA mice do not spontaneously develop a haematopoietic phenotype consistent with SAA, even at extreme old age. This suggests that HSC quiescence restricts the acquisition of DNA damage during aging and preserves the functional integrity of the stem cell pool. In line with this hypothesis, we provide an extended time course analysis of the response of FA knockout mice to chronic inflammatory stress and show that enforced HSC proliferation leads to a highly penetrant SAA phenotype, which closely resembles the progression of the disease in FA patients.

[1]  M. Grompe,et al.  In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia. , 1999, Blood.

[2]  A. Berns,et al.  Mice with a targeted disruption of the Fanconi anemia homolog Fanca. , 2000, Human molecular genetics.

[3]  H. Nakauchi,et al.  Age-Associated Characteristics of Murine Hematopoietic Stem Cells , 2000, The Journal of experimental medicine.

[4]  C. McKerlie,et al.  Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. , 2003, Human molecular genetics.

[5]  Marianne Berwick,et al.  A 20-year perspective on the International Fanconi Anemia Registry (IFAR). , 2003, Blood.

[6]  I. Weissman,et al.  Cell intrinsic alterations underlie hematopoietic stem cell aging. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Lio’,et al.  Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.

[8]  F. Rosselli,et al.  The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities , 2009, Nature Cell Biology.

[9]  Andreas Trumpp,et al.  Hematopoietic Stem Cells Reversibly Switch from Dormancy to Self-Renewal during Homeostasis and Repair , 2008, Cell.

[10]  Andreas Trumpp,et al.  IFNα activates dormant haematopoietic stem cells in vivo , 2009, Nature.

[11]  I. Hickson,et al.  Replication stress induces sister-chromatid bridging at fragile site loci in mitosis , 2009, Nature Cell Biology.

[12]  A. D’Andrea,et al.  Mouse models of Fanconi anemia. , 2009, Mutation research.

[13]  David A. Williams,et al.  Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells. , 2009, Blood.

[14]  D. Pellman,et al.  Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. , 2010, The Journal of clinical investigation.

[15]  Nathan C Boles,et al.  Quiescent hematopoietic stem cells are activated by IFNγ in response to chronic infection , 2010, Nature.

[16]  G. Daley,et al.  Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage. , 2010, Blood.

[17]  K. J. Patel,et al.  Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice , 2011, Nature.

[18]  Sebastian Bonhoeffer,et al.  Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation , 2011, The Journal of experimental medicine.

[19]  G. de Haan,et al.  Aging of hematopoietic stem cells: Intrinsic changes or micro-environmental effects? , 2011, Current opinion in immunology.

[20]  J. Soulier,et al.  Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. , 2012, Cell stem cell.

[21]  Mithat Gonen,et al.  Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.

[22]  Joshua F. McMichael,et al.  The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.

[23]  K. J. Patel,et al.  Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function , 2012, Nature.

[24]  A. Lier,et al.  Disrupted Signaling through the Fanconi Anemia Pathway Leads to Dysfunctional Hematopoietic Stem Cell Biology: Underlying Mechanisms and Potential Therapeutic Strategies , 2012, Anemia.

[25]  K. Cimprich,et al.  Causes and consequences of replication stress , 2013, Nature Cell Biology.

[26]  S. Miyano,et al.  Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients. , 2013, Blood.

[27]  P. Kurre,et al.  Fetal origins of hematopoietic failure in a murine model of Fanconi anemia. , 2013, Blood.

[28]  T. Graf,et al.  CD41 expression marks myeloid-biased adult hematopoietic stem cells and increases with age. , 2013, Blood.

[29]  D. Papatsenko,et al.  Divisional History and Hematopoietic Stem Cell Function during Homeostasis , 2014, Stem cell reports.

[30]  I. Weissman,et al.  Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. , 2014, Cell stem cell.

[31]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[32]  P. Sung,et al.  Stress and DNA repair biology of the Fanconi anemia pathway. , 2014, Blood.

[33]  Marcel J T Reinders,et al.  Somatic mutations found in the healthy blood compartment of a 115-yr-old woman demonstrate oligoclonal hematopoiesis , 2014, Genome research.

[34]  Allon M. Klein,et al.  Clonal dynamics of native haematopoiesis , 2014, Nature.

[35]  M. L. Beau,et al.  Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells , 2014, Nature.

[36]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[37]  K. J. Patel,et al.  Why does the bone marrow fail in Fanconi anemia? , 2014, Blood.

[38]  H. Walden,et al.  The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder. , 2014, Annual review of biophysics.

[39]  David A. Williams,et al.  Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells , 2015, Nature.

[40]  B. Vogelstein,et al.  Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.

[41]  Tim Holland-Letz,et al.  Fundamental properties of unperturbed haematopoiesis from stem cells in vivo , 2015, Nature.

[42]  A. Morris,et al.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, BDJ.